It will be interesting to investigate whether some tumor suppressive functions of SMURF2 [52] could be related to its negative effects on RUNX2 and whether AKT-mediated degradation of SMURF2 can occur in tumors, explaining the high levels of RUNX2 in certain types of cancer [40]. This evidence concerns the gene RUNX2 and neoplasm.